Manufacturing, Cell Therapies

IVERIC bio, Catalent Partner on Gene Therapy for Orphan Inherited Retinal Diseases

June 19, 2019

IVERIC bio and Catalent Biologics have entered into a strategic manufacturing agreement for gene therapy product candidates to treat orphan inherited retinal diseases.

Lonza, Gamida Cell Form Commercial Cell-Therapy Manufacturing Pact

June 19, 2019

The companies have signed a strategic multi-year manufacturing agreement for the future commercial production a late-phase investigational cell therapy.

FUJIFILM Invests in New Continuous Processing Facility

June 07, 2019

The $10-million investment will include a 500-L single-use perfusion bioreactor and seven patented downstream processing units.

Iovance Biotherapeutics Builds US Facility for Autologous Cell Therapy Products

May 30, 2019

A new facility to be built in the Philadelphia Navy Yard will support commercial production for autologous tumor-infiltrating lymphocyte cell therapy products from Iovance Biotherapeutics.

Software Automates Cell Therapy Manufacturing

May 15, 2019

GE Healthcare launches Chronicle GMP-compliant automation software for cell therapy manufacturing.

The Link Between Manufacturing and Commercialization in Gene and Cell Therapies

May 15, 2019

The highly customized nature of cell and gene therapy production means that manufacturing innovations for one therapy may not be easily transferable to others.

Advancing Cell Therapy for Diabetes

May 13, 2019

Pharmaceutical Technology's In the Lab eNewsletter

Harvard University researchers used single-cell sequencing to identify a protein expressed uniquely by insulin-producing beta cells created from stem cells in the laboratory.